Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Vsa polja
Naslov
Avtor
Tema
Signatura
ISBN/ISSN
Oznaka
Išči
Napredno
The value of molecular monitor...
Citiraj
Pošljite SMS
Pošljite email
Natisni
Izvozi zadetek
Izvozi v RefWorks
Izvozi v EndNoteWeb
Izvozi v EndNote
Permanent link
The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.
Bibliografske podrobnosti
Main Authors:
Foroni, L
,
Mitchell, W
,
Rai, L
,
Richards, S
,
Fielding, A
,
Goldstone, A
Format:
Conference item
Izdano:
2005
Zaloga
Opis
Podobne knjige/članki
Knjižničarski pogled
Podobne knjige/članki
Molecular monitoring of residual disease (MRD) during induction and intensification phases in low risk adult B cell ALL treated according to the MRC UKALL12 protocol.
od: Foroni, L, et al.
Izdano: (2005)
Value of molecular monitoring for minimal residual disease preceding autologous SCT following diagnosis of B cell acute lymphoblastic leukemia in patients treated with the MRC UKALL12 protocol.
od: Foroni, L, et al.
Izdano: (2005)
Clinical effect of Imatinib following remission induction in adult Philadelphia chromosome-positive acute lymphoblastic leukaemia: early results from the MRC UKALL12 Study
od: Patel, B, et al.
Izdano: (2006)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
od: Fielding, A, et al.
Izdano: (2007)
The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study
od: Patel, B, et al.
Izdano: (2005)